Bioxyne Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioxyne Limited with three other
companies in this sector in Australia:
sales of 2.07 million Australian Dollars [US$1.48 million]
of which 97%
was United States),
(1.62 million Australian Dollars [US$1.16 million]
(2.04 million Australian Dollars [US$1.46 million]
of which 100%
was Dermaportation & ET Technologies).
During the year ended June of 2018, sales at
Bioxyne Limited were A$2.17 million (US$1.56 million).
increase of 8.1%
versus 2017, when the company's sales were A$2.01 million.
This was the third consecutive year of growth at Bioxyne Limited.